Waldron Private Wealth LLC Has $585,000 Stock Holdings in Colgate-Palmolive (NYSE:CL)

Waldron Private Wealth LLC grew its position in shares of Colgate-Palmolive (NYSE:CL) by 2.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,632 shares of the company’s stock after purchasing an additional 118 shares during the quarter. Waldron Private Wealth LLC’s holdings in Colgate-Palmolive were worth $585,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in CL. Fisher Asset Management LLC boosted its stake in shares of Colgate-Palmolive by 1,010.7% during the fourth quarter. Fisher Asset Management LLC now owns 3,210 shares of the company’s stock valued at $256,000 after purchasing an additional 2,921 shares in the last quarter. Park Avenue Securities LLC boosted its stake in shares of Colgate-Palmolive by 20.5% during the first quarter. Park Avenue Securities LLC now owns 7,368 shares of the company’s stock valued at $663,000 after purchasing an additional 1,252 shares in the last quarter. RFG Advisory LLC boosted its stake in shares of Colgate-Palmolive by 6.4% during the first quarter. RFG Advisory LLC now owns 5,299 shares of the company’s stock valued at $477,000 after purchasing an additional 317 shares in the last quarter. Global Assets Advisory LLC acquired a new stake in shares of Colgate-Palmolive during the first quarter valued at about $3,505,000. Finally, DGS Capital Management LLC boosted its stake in shares of Colgate-Palmolive by 110.1% during the first quarter. DGS Capital Management LLC now owns 5,510 shares of the company’s stock valued at $496,000 after purchasing an additional 2,888 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now owns 11,755 shares in the company, valued at $1,220,874.30. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now owns 11,755 shares of the company’s stock, valued at $1,220,874.30. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Panagiotis Tsourapas sold 14,794 shares of the company’s stock in a transaction on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total value of $1,522,894.36. Following the transaction, the insider now directly owns 5,146 shares in the company, valued at $529,729.24. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 43,490 shares of company stock worth $4,486,063 in the last quarter. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Trading Up 0.3 %

NYSE CL opened at $99.68 on Wednesday. The business has a 50 day moving average price of $103.38 and a 200-day moving average price of $97.83. Colgate-Palmolive has a 52 week low of $71.46 and a 52 week high of $109.30. The company has a market cap of $81.78 billion, a price-to-earnings ratio of 31.54, a P/E/G ratio of 3.54 and a beta of 0.40. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 16.90.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, July 26th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.87 by $0.04. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The business had revenue of $5.06 billion during the quarter, compared to the consensus estimate of $5 billion. During the same quarter in the prior year, the company posted $0.77 earnings per share. Colgate-Palmolive’s revenue was up 4.9% compared to the same quarter last year. As a group, equities analysts expect that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a dividend of $0.50 per share. The ex-dividend date is Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 2.01%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 63.29%.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. Redburn Atlantic raised Colgate-Palmolive to a “hold” rating in a research note on Thursday, August 1st. Hsbc Global Res lowered Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 26th. Wells Fargo & Company lowered Colgate-Palmolive from an “equal weight” rating to an “underweight” rating and set a $100.00 price objective on the stock. in a research note on Monday, September 16th. Barclays lifted their price objective on Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a research note on Monday, July 29th. Finally, TD Cowen lifted their price objective on Colgate-Palmolive from $110.00 to $115.00 and gave the stock a “buy” rating in a research note on Tuesday, July 30th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $106.00.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.